At the conclusion of this live activity, participants should be better able to:
- Apply the most current diagnostic methods and treatments for common skin diseases
- Identify potential adverse effects and levels of efficacy of newer dermatologic treatments
- Explain the role of available biologic agents in treating psoriasis and how to incorporate them into practice
- Incorporate new approaches for managing acne, rosacea, contact dermatitis and actinic keratosis
- Discuss new approaches in the treatment of moles, melanoma and other skin cancers
- Formulate approaches to the management of cutaneous lupus
- Analyze treatments for the management of onychomycosis, other fungi and warts
- Develop a strategy for the optimal management of atopic dermatitis, including rotational regimen
- Describe the rationales and mechanisms of action of the new and emerging therapies for AD, particularly the recently approved and emerging agents
- Incorporate the recent research advances in understanding and treating pediatric dermatology issues such as atopic dermatitis and psoriasis
- Discuss approaches to treating dermatologic conditions in the pediatric patient
- Utilize dermoscopy in diagnosis and detection of skin cancers
- Compare treatment options for pseudofolliculitis barbae and acne keloidalis nucha
- Discuss the latest recommendations for patch testing/phototesting and explain how they should be used to improve the treatment of allergic conditions
- Utilize enhanced practice management techniques and tools to increase office efficiency and facilitate patient care
- Integrate into daily practice evidence-based recommendations on new and emerging therapies for common and uncommon dermatologic diseases
- Recognize cutaneous manifestations of common systemic diseases
- Describe the mechanisms of action, efficacy and safety of the current and emerging agents used to treat psoriasis as well as appropriate patient selection.
This activity has been planned and implemented in accordance with the requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and Global Academy for Medical Education. The University of Louisville is accredited by the ACCME to provide continuing medical education for physicians.
The University of Louisville designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The self-assessment program offered at the 18th Annual Caribbean Dermatology Symposium is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 20 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.